HFRS, Seoul virus, and hantavirus beyond the lungs
How kidney-focused hantavirus illness (HFRS) differs from HPS, what the CDC says about Seoul virus in the U.S., and a brief note on Andes virus—sourced overview only.
Some searches are about kidney failure hantavirus, Seoul virus, HFRS, or hantavirus hemorrhagic fever. In CDC materials, Hantavirus Pulmonary Syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS) are different clinical patterns caused by different hantaviruses in different regions — but both remain rodent-associated. This page exists so readers do not collapse the two into one mental model and end up reasoning from the wrong picture.
Why this distinction matters
If you read U.S.-focused HPS material and then encounter international coverage of “hantavirus hemorrhagic fever,” it is easy to assume both phrases describe the same illness. They don’t. Mixing them up leads to wrong intuitions on:
- Which rodents matter — deer mice for the most common U.S. HPS scenario; different reservoirs for HFRS-causing hantaviruses including Seoul virus, which is rat-associated.
- What organs are most affected — lungs for HPS, kidneys (and broader hemorrhagic features) for HFRS in CDC framing.
- What clinical course to expect — different timelines, different complications, different supportive-care emphasis.
- Where in the world these illnesses dominate — HPS is the U.S. story most of this site focuses on; HFRS-causing hantaviruses include strains with broader global presence.
For the U.S.-deer-mouse picture see Hantavirus in the United States. For the symptom-side of HPS see Symptoms and HPS incubation and symptom timeline.
HPS vs HFRS (conceptual)
- HPS (emphasized for many U.S. readers) primarily involves severe lung illness. The CDC discusses deer mice for the most common U.S. HPS scenario on its consumer pages.
- HFRS is described as a group of illnesses with kidney involvement, with severity varying by virus. Some HFRS-causing hantaviruses are associated with mild illness; others can be severe.
The CDC’s HFRS clinician brief notes that in the United States, Seoul virus is the only hantavirus that causes HFRS, while the consumer “About hantavirus” page explains that Seoul virus is found worldwide, including in the United States, as a cause of HFRS.
The CDC explicitly keeps clinical overviews separate for HPS and HFRS. Treat that as a hint about the level of distinction the agency wants readers to carry.
Seoul virus in the United States
Seoul virus is the part of the HFRS picture U.S. readers most often need to understand:
- The CDC’s consumer overview describes Seoul virus as found worldwide, including in the United States.
- It is associated with rats rather than deer mice — a different reservoir than the one most U.S. HPS messaging emphasizes.
- The clinical pattern in U.S. cases tends to be on the milder end of the HFRS spectrum compared with some other HFRS-causing viruses, but illness can still be significant; the CDC clinician brief is the place for clinical detail.
For everyday risk reduction, the prevention story still rhymes with the HPS prevention story: keep rodents out of buildings, do not generate dust from rodent waste, follow CDC cleanup guidance. See Prevention and Rodent droppings cleanup.
Andes virus (person-to-person nuance)
For U.S.-focused hantavirus education, person-to-person spread is not the headline concern in CDC consumer materials for typical scenarios. Separately, the CDC’s HPS clinician brief notes that Andes virus in South America has reportedly had person-to-person transmission — an example of why virus-specific and region-specific reading matters.
Important framing for searchers:
- “Andes virus” is a specific hantavirus tied to specific geography. International outbreak coverage that mentions person-to-person spread is often discussing Andes-virus context, which is not the same as everyday U.S. exposure picture.
- This is a real distinction in surveillance and clinical literature, not editorial spin. WHO and ECDC reports on specific clusters can read very differently from a U.S.-focused CDC consumer page for exactly this reason.
- For headline-driven anxiety from current outbreak coverage, see Cruise ship outbreak: what U.S. readers should know and Can hantavirus spread person to person?.
Exposure prevention still rhymes
HFRS transmission routes described by the CDC still center on rodent urine, feces, saliva, nesting material, and unsafe cleanup — not casual contact in the way people think about colds. Practical prevention on this site remains the same:
- Prevention — Seal Up, Trap Up, Clean Up.
- Rodent droppings cleanup — dust-aware cleaning method.
- Seasonal cabins, storage, and RVs — opening-day checklist.
The differences between HPS and HFRS show up most strongly in clinical presentation and regional epidemiology, less so in everyday consumer prevention behavior.
Treatment notes (very high level)
Consumer CDC pages describe supportive care broadly. The HFRS clinician brief discusses supportive management and notes dialysis may be needed for severe fluid overload; it also discusses ribavirin in HFRS in a way that is not the same as summarizing HPS trials. Do not extrapolate drug names across syndromes — read the CDC directly.
For the lay-reader version of HPS supportive-care framing see Treatment and recovery.
Where this page does and does not try to go
This is an orientation page, not a clinical reference. It exists so non-clinicians can:
- Tell HPS and HFRS apart at the level of the words on a CDC page.
- Recognize Seoul virus when it appears in international reading.
- Avoid pulling Andes-virus, person-to-person reasoning into U.S. everyday risk decisions.
For deeper clinical detail, the CDC clinician briefs are the right next stop. For the U.S. consumer prevention story this site is built around, the home-focused pages are linked above.
Related guides
- Hantavirus in the United States — deer-mouse HPS framing for U.S. readers.
- Can hantavirus spread person to person? — U.S. baseline vs. Andes nuance.
- Cruise ship outbreak: what U.S. readers should know — current outbreak context, calmly framed.
- Symptoms — HPS symptom outline.
- Treatment and recovery — supportive-care themes.
- Transmission — U.S. person-to-person framing vs rodent exposure.
Sources cited on this page
- CDC — About Hantavirus (HFRS overview) · accessed 2026-05-07T00:00:00.000Z
- CDC — Clinician brief (HFRS) · accessed 2026-05-07T00:00:00.000Z
- CDC — Clinician brief (HPS) · accessed 2026-05-07T00:00:00.000Z
- WHO — Hantavirus health topic · accessed 2026-05-07T00:00:00.000Z
Updates on this topic, by email
When CDC or WHO guidance changes, you’ll hear about it in plain language. Unsubscribe anytime.